Alzheimer’s & Parkinson’s

Oxidative stress in Parkinson’s disease and other neurodegenerative disorders.

Molecular bases of the treatment of Alzheimer’s disease with antioxidants: prevention of oxidative stress.

Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson’s disease.

The effects of stress and aging on glutathione metabolism

Glutathione in Parkinson’s disease: a link between oxidative stress and mitochondrial damage?

Parkinson’s disease: a disorder due to nigral glutathione deficiency?

Dopamine turnover and glutathione oxidation: implications for Parkinson disease.

Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia.

Glutathione peroxidase in early and advanced Parkinson’s disease.

Reduced intravenous glutathione in the treatment of early Parkinson’s disease.

Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson’s disease.

Glutathione–a review on its role and significance in Parkinson’s disease.

Glutathione and Parkinson’s disease: is this the elephant in the room?

Idiopathic Parkinson’s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.

Idiopathic Parkinson’s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.

Leave a Reply Cancel reply